An Overview of the Bacterial Carbonic Anhydrases

Overview

Journal Metabolites

Publisher MDPI

Date 2017 Nov 16

PMID 29137134

Citations 104

Authors

Claudiu T Supuran

Clemente Capasso

Affiliations

Soon will be listed here.

Abstract

Bacteria encode carbonic anhydrases (CAs, EC 4.2.1.1) belonging to three different genetic families, the α-, β-, and γ-classes. By equilibrating CO₂ and bicarbonate, these metalloenzymes interfere with pH regulation and other crucial physiological processes of these organisms. The detailed investigations of many such enzymes from pathogenic and non-pathogenic bacteria afford the opportunity to design both novel therapeutic agents, as well as biomimetic processes, for example, for CO₂ capture. Investigation of bacterial CA inhibitors and activators may be relevant for finding antibiotics with a new mechanism of action.

Citing Articles

Mineral Carbonation for Carbon Sequestration: A Case for MCP and MICP.

Wilcox S, Mulligan C, Neculita C Int J Mol Sci. 2025; 26(5).

PMID: 40076853 PMC: 11900583. DOI: 10.3390/ijms26052230.

Heterologous Expression and Functional Verification of Extracellular Carbonic Anhydrases in from Mariana Trench.

Wang X, Wang P, Zhao H, He Y, Qu C, Miao J Molecules. 2025; 29(24.

PMID: 39769999 PMC: 11677799. DOI: 10.3390/molecules29245911.

Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond.

Paciotti R, Carradori S, Angeli A, DAgostino I, Ferraroni M, Coletti C Arch Pharm (Weinheim). 2025; 358(1):e2400776.

PMID: 39763011 PMC: 11704030. DOI: 10.1002/ardp.202400776.

Exploring aliphatic sulfonamides as multiclass inhibitors of the carbonic anhydrases from the pathogen bacterium Vibrio cholerae.

Paoletti N, Giovannuzzi S, Bonardi A, De Luca V, Capasso C, Nocentini A Arch Pharm (Weinheim). 2024; 358(1):e2400814.

PMID: 39686870 PMC: 11650360. DOI: 10.1002/ardp.202400814.

Bacterial Metallostasis: Metal Sensing, Metalloproteome Remodeling, and Metal Trafficking.

Capdevila D, Rondon J, Edmonds K, Rocchio J, Villarruel Dujovne M, Giedroc D Chem Rev. 2024; 124(24):13574-13659.

PMID: 39658019 PMC: 11672702. DOI: 10.1021/acs.chemrev.4c00264.

References

Vullo D, Kumar R, Scozzafava A, Capasso C, Ferry J, Supuran C . Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens. Bioorg Med Chem Lett. 2013; 23(24):6706-10. DOI: 10.1016/j.bmcl.2013.10.037. View

Achari A, Somers D, Champness J, Bryant P, Rosemond J, Stammers D . Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat Struct Biol. 1997; 4(6):490-7. DOI: 10.1038/nsb0697-490. View

Supuran C . Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol. 2016; 12(4):423-31. DOI: 10.1517/17425255.2016.1154534. View

Ferraroni M, Del Prete S, Vullo D, Capasso C, Supuran C . Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Acta Crystallogr D Biol Crystallogr. 2015; 71(Pt 12):2449-56. DOI: 10.1107/S1399004715018635. View

Vullo D, Del Prete S, De Luca V, Carginale V, Ferraroni M, Dedeoglu N . Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem Lett. 2016; 26(5):1406-10. DOI: 10.1016/j.bmcl.2016.01.072. View

Supuran C . Bortezomib inhibits bacterial and fungal β-carbonic anhydrases. Bioorg Med Chem. 2016; 24(18):4406-4409. DOI: 10.1016/j.bmc.2016.07.035. View

Modak J, Liu Y, Supuran C, Roujeinikova A . Structure-Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic Anhydrase. J Med Chem. 2016; 59(24):11098-11109. DOI: 10.1021/acs.jmedchem.6b01333. View

Huang S, Xue Y, Chirica L, Lindskog S, Jonsson B . Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide. J Mol Biol. 1998; 283(1):301-10. DOI: 10.1006/jmbi.1998.2077. View

Covarrubias A, Bergfors T, Jones T, Hogbom M . Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis. J Biol Chem. 2005; 281(8):4993-9. DOI: 10.1074/jbc.M510756200. View

10.

Shahidzadeh R, Opekun A, Shiotani A, Graham D . Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter. 2005; 10(2):136-8. DOI: 10.1111/j.1523-5378.2005.00306.x. View

11.

Diaz J, Fernandez Baldo M, Echeverria G, Baldoni H, Vullo D, Soria D . A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents. J Enzyme Inhib Med Chem. 2016; 31(sup2):51-62. DOI: 10.1080/14756366.2016.1187143. View

12.

Capasso C, Supuran C . An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?. J Enzyme Inhib Med Chem. 2014; 30(2):325-32. DOI: 10.3109/14756366.2014.910202. View

13.

Abdel Gawad N, Amin N, Elsaadi M, Mohamed F, Angeli A, De Luca V . Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines. Bioorg Med Chem. 2016; 24(13):3043-3051. DOI: 10.1016/j.bmc.2016.05.016. View

14.

Carta F, Maresca A, Covarrubias A, Mowbray S, Jones T, Supuran C . Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Bioorg Med Chem Lett. 2009; 19(23):6649-54. DOI: 10.1016/j.bmcl.2009.10.009. View

15.

Del Prete S, Vullo D, Osman S, Alothman Z, Supuran C, Capasso C . Sulfonamide inhibition profiles of the β-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia. Bioorg Med Chem. 2017; 25(13):3555-3561. DOI: 10.1016/j.bmc.2017.05.007. View

16.

Capasso C, Supuran C . Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem. 2013; 29(3):379-87. DOI: 10.3109/14756366.2013.787422. View

17.

Del Prete S, Perfetto R, Rossi M, Alasmary F, Osman S, Alothman Z . A one-step procedure for immobilising the thermostable carbonic anhydrase (SspCA) on the surface membrane of Escherichia coli. J Enzyme Inhib Med Chem. 2017; 32(1):1120-1128. PMC: 6010132. DOI: 10.1080/14756366.2017.1355794. View

18.

Capasso C, Supuran C . Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance. Curr Top Med Chem. 2017; 17(11):1237-1248. DOI: 10.2174/1568026617666170104101058. View

19.

Supuran C . Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008; 7(2):168-81. DOI: 10.1038/nrd2467. View

20.

Cobaxin M, Martinez H, Ayala G, Holmgren J, Sjoling A, Sanchez J . Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditions. Microb Pathog. 2013; 66:5-13. DOI: 10.1016/j.micpath.2013.11.002. View